Home  About us Intellectual Property Technology Management TeamContact




InterK Peptide Therapeutics is developing peptide-based immunotherapeutic candidates based on the activation of a single kinase which leads to the production of cytokines required to maintain an adequate immune response.

These compounds have been shown to exert their beneficial effect not only on normal immune cells but also on immune cells that have become exhausted. 

The Company’s immediate focus is to evaluate the contribution its compounds may make in the field of immuno-oncology used either alone or as combinatorial/adjunctive therapy.

InterK compounds may also have wider application across a range of non-cancer diseases and conditions where restoration of a compromised immune system or enhancement of function by normal immune cells is warranted.

Early stage development of peptide based therapeutic candidates in Sydney Australia


Contact Us
Phone +61 418 212 254
Email mail@interk.com.au


© Inter-K Pty Ltd 2015 | Terms of Service | Privacy Policy | Graphic Design by Simon Creedy



Key words and phrases